Business Context and Reporting Period
This Form 8-K Current Report was filed by Astrotech Corporation on August 10, 2011. The filing addresses a material modification to the rights of security holders regarding the company's poison pill defense mechanism.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder rights rather than financial performance.
Material Changes
- Extension of Rights Agreement: The Company entered into Amendment Two to its Rights Agreement with American Stock Transfer & Trust Company, LLC.
- New Expiration Date: The expiration date for the preferred share purchase rights (Rights) was extended from August 10, 2011, to August 10, 2012.
- Historical Context: The Rights were originally declared on July 29, 2009, and previously extended via Amendment One on July 29, 2010.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk addressed is the potential for a hostile takeover, which the Rights Agreement is designed to deter. The extension of the Rights indicates the Board's continued intent to maintain this defensive measure for another year.
Investor Verification Checklist
- Verify the full terms of Amendment Two to the Rights Agreement (Exhibit 4.1) to understand redemption triggers and exchange ratios.
- Confirm the number of outstanding common shares to calculate the total number of Rights in circulation.
- Review recent 10-Q or 10-K filings for the most current financial position, as this 8-K contains no financial data.
- Monitor for any future announcements regarding the redemption or exchange of the Rights prior to the new August 10, 2012, expiration date.